Arlene Wolny is the Global Head of Regulatory Affairs at Biocon Biologics. Prior to their current role, Arlene held positions at Sandoz as the Head US Regulatory Affairs Sandoz Biopharmaceuticals and at Novartis Pharmaceuticals in various executive and leadership positions within the regulatory affairs field. Arlene holds an MBA in Finance from Columbia Business School, a PhD in Pharmacology from the University of Basel, a BS in Chemistry from Stony Brook University, and a Master of Science from The Ohio State University School of Veterinary Medicine.
Sign up to view 0 direct reports
Get started